July, 2015 | The Wall Street Analyzer

DelMar Pharmaceuticals (OTCQX:DMPI) CEO Interview

July 30, 2015 The Wall Street Analyzer Comments Off

Interview with Jeff Bacha, CEO […]

OCI Partners LP Schedules 2015 Second Quarter Results Conference Call

July 30, 2015 The Wall Street Analyzer Comments Off

NYSE:OCIP […]

Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors

July 30, 2015 The Wall Street Analyzer Comments Off

Up to $9.5 Million in Debt Financing and $12 Million in Equity Financing.

Company to Advance its Immuno-Dermatology and Inflammatory Bowel Disease Product Candidates
Lead Compound Bertilimumab, First-in-Class Autoimmune Therapy, a Priority
[…]

Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

July 20, 2015 The Wall Street Analyzer Comments Off

NASDAQ:EDUC […]

Pacific Energy Development Announces Commencement of Drilling This Week on Seven New Wattenberg Wells

July 20, 2015 The Wall Street Analyzer Comments Off

Will Also Participate in Additional Wattenberg Well […]

WSA Spotlights Three Canadian Companies in June That Are Making Big Moves

July 15, 2015 The Wall Street Analyzer Comments Off

Wall Street Analyzer’s CEO Interview Series […]

CEO Interviews

AirBoss of America Corp (TSX:BOS) (OTC:ABSSF) Management Interview

July 14, 2015 The Wall Street Analyzer Comments Off

Management Interview […]

Chanticleer Holdings, Inc (NASDAQ:HOTR) CEO Interview

July 7, 2015 The Wall Street Analyzer Comments Off

Chanticleer Holdings, Inc (NASDAQ:HOTR) President and CEO: Michael Pruitt THIS INTERVIEW HAS EXPIRED

OCI Partners LP Announces Closing of New Incremental Term Loan

July 6, 2015 The Wall Street Analyzer Comments Off

(NYSE:OCIP) […]

Featured Interviews

Zerify (OTCQB: ZRFY)

November 17, 2022 0

ABOUT: Zerify Inc. (OTCQB: ZRFY), formerly StrikeForce Technologies, is an Edison, New Jersey-based company with over two decades of experience in cybersecurity solutions. The company helps to prevent cyber theft and data security breaches for […]

CEO Interviews

C-COM Satellite Systems Inc. (TSXV: CMI) (OTCQB: CYSNF)

November 4, 2022 0

ABOUT: C-COM Satellite Systems Inc. is a pioneer and world leader in the design, development, and manufacture of transportable and mobile satellite-based antenna systems. The Company has sold more than 10,000 antenna systems, in over […]

Featured Interviews

Xortx Therapeutics (CSE: XRX) (NASDAQ: XRTF)

October 25, 2022 0

ABOUT: XORTX is a pharmaceutical company with two clinically advanced products in development: 1) our lead program in XRx-008 for ADPKD; and 2) our secondary program in XRx-101 for acute kidney and other acute organ […]

CEO Interviews

Scottie Resources (TSXV: SCOT)(OTCQB: SCTSF) Brad Rourke, CEO and President

October 24, 2022 0

INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street. This is Juan Costello, Senior Analyst with The Wall Street Analyzer. Joining us today is Brad Rourke, CEO and President at Scottie Resources. The company trades on […]

CEO Interviews

Pro-Dex, Inc (NASDAQ: PDEX) CEO Interview Update

October 24, 2022 0

ABOUT: Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used […]

Month: July 2015

DelMar Pharmaceuticals (OTCQX:DMPI) CEO Interview

OCI Partners LP Schedules 2015 Second Quarter Results Conference Call

Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors

Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

Pacific Energy Development Announces Commencement of Drilling This Week on Seven New Wattenberg Wells

WSA Spotlights Three Canadian Companies in June That Are Making Big Moves

AirBoss of America Corp (TSX:BOS) (OTC:ABSSF) Management Interview

Chanticleer Holdings, Inc (NASDAQ:HOTR) CEO Interview

OCI Partners LP Announces Closing of New Incremental Term Loan

Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

Client Testimonials: